FDA Chief Warns Generics Industry On Safety Lapses

Law360, New York (February 22, 2013, 1:35 PM EST) -- The U.S. Food and Drug Administration's top official brought a blunt message to the Generic Pharmaceutical Association on Friday, warning manufacturers that quality-control issues threaten to shake public confidence and are contributing unacceptably to drug shortages.

In a keynote address at the GPhA's annual meeting in Orlando, FDA Commissioner Margaret Hamburg rattled off a laundry list of recent safety lapses involving generics, brand-name medicines and compounded drugs, including pills laced with glass particles, pharmaceuticals infected with bacteria, prescription drugs mixed with over-the-counter medications and drugs with...
To view the full article, register now.